findmyKOL
Clinical trialNCT02891161TerminatedPhase 1/PHASE2Interventional

Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

SponsorMonika Joshi, MDEnrollment26Urothelial Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Iowa Hospital and Clinics

    Iowa City, Iowa, United States

  • Nebraska Methodist Hospital

    Omaha, Nebraska, United States

  • Rutgers Cancer Institute of New Jersey

    New Brunswick, New Jersey, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Penn State Cancer Intsitute

    Hershey, Pennsylvania, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

  • Froedtert & the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Nov 2016
Primary completion
6 Aug 2019
Completion
27 Apr 2022
Last update posted
27 Nov 2024
Registered enrollment
26
Registry id
NCT02891161

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.